Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,730,407
+$4,042,005 QoQ
Shares Held
274,911
+32.9% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#93
of 561 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $347,338,125 across 26 Biotechnology names. BMRN ranks #10 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
455,392 | $48,553,895 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
463,146 | $36,250,437 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
448,143 | $33,377,690 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
51,333 | $32,008,178 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
99,584 | $29,977,771 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
429,904 | $23,618,925 | |
| 7 | EXEL |
Exelixis, Inc.
|
400,859 | $21,810,738 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
54,489 | $20,251,926 |
All Filings in BMRN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,730,407 | 274,911 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,688,402 | 206,911 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,666,582 | 229,961 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,346,991 | 375,683 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,519,197 | 227,746 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,741,242 | 123,656 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $19,882,010 | 302,480 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,003,251 | 142,314 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,880,232 | 34,984 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $293,986 | 3,366 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $18,413,327 | 190,970 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,280,141 | 161,394 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $12,999,919 | 149,976 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $12,062,038 | 124,044 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,009,162 | 106,379 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,116,504 | 107,544 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,291,182 | 39,715 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,515,015 | 19,650 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,235,398 | 13,983 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,082,832 | 14,010 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,934,222 | 23,181 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,014,703 | 13,438 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||